YOLFTbeta
Genomtec S.A.

Genomtec S.A.

GMT · WAR · Healthcare / Medical Devices

2.61PLN-0.15 (-5.62%)

Price History

Full chart

Market Stats

Previous Close2.76
Open2.67
Day Range2.58 – 2.75
52-Week Range3.00 – 6.93
Volume29.44K
Market Cap51.45M
P/E (TTM)0.00
Forward P/E0.00
EPS-0.62
Dividend Yield0.00%
Beta0.31
50-Day Avg3.74
200-Day Avg4.51

About

Genomtec S.A. researches and develops a mobile point of care genetic testing platform for the clinical diagnostics market in Poland. The company's flagship project is the Genomtec ID, a diagnostic platform that enables the detection of pathogens, such as viruses, bacteria, and fungi, as well as genetic mutations through the analysis of biological material of patients using swabs, urine, and saliva. It also develops SNAAT chemistry for mutation detection in oncology. In addition, the company develops and commercializes tests used in the detection of viral infectious diseases and other areas. Genomtec S.A. was founded in 2016 and is based in Wroclaw, Poland.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEOMr. Miron Tokarski Ph.D.
  • Employees32
  • HeadquartersBierutowska Street 57-59, Wroclaw, Poland, 51-317, Poland
  • Websitehttps://www.genomtec.com

Leadership

  • Mr. Miron Tokarski Ph.D.Co-Founder, CEO & Member of the Management Board
  • Mr. Michal WachowskiCFO & Member of the Management Board
  • Mr. Lee HuntleyCTO & Member of the Management Board
  • Mr. Henryk Roguszczak M.Sc.Co-founder & Chief Designer
  • Dr. Malgorzata Malodobra-MazurCo-founder and Director of Research & Development

Financials

Income Statement

Currency: PLN2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue152.72K20.00K219.00K40.00K1.00K1.00K21.00K
Growth (%)--86.90%+995.00%-81.74%-97.50%0.00%+2000.00%
Cost of Revenue2.92M248.00K595.00K857.00K794.00K2.33M2.80M
Gross Profit-2.77M-228.00K-376.00K-817.00K-793.00K1.00K-2.78M
Gross Margin-1811.39%-1140.00%-171.69%-2042.50%-79300.00%100.00%-13238.10%
Operating Expense101.47K14.25M10.16M11.14M7.93M11.06M12.00M
Operating Income-2.87M-14.48M-10.54M-11.95M-8.73M-11.05M-14.78M
Operating Margin-1877.83%-72405.00%-4812.79%-29882.50%-872700.00%-1105500.00%-70371.43%
EBITDA-1.50M-10.67M-6.58M-11.06M-7.76M-8.72M-11.98M
EBITDA Margin-984.09%-53365.00%-3003.65%-27640.00%-775600.00%-872500.00%-57033.33%
Net Income-1.45M-10.94M-7.12M-11.93M-9.01M-11.21M-10.43M
Net Income Margin-947.38%-54695.00%-3248.86%-29820.00%-901300.00%-1120800.00%-49671.43%
R&D-3.42M4.83M3.24M793.00K4.31M5.58M
R&D as % of Total Revenue-17110.00%2206.39%8100.00%79300.00%431000.00%26571.43%
Interest Expense9.94K18.00K28.00K292.00K236.00K134.00K306.00K
Interest Expense % of Total Revenue6.51%90.00%12.79%730.00%23600.00%13400.00%1457.14%

Balance Sheet

Currency: PLN2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets2.91M9.37M4.22M11.80M15.97M17.04M15.42M
Total Liabilities1.80M1.80M3.48M6.87M7.67M9.44M4.71M
Total Equity1.11M7.57M723.00K4.89M8.30M7.60M9.21M
Cash1.42M7.30M1.38M4.14M4.17M6.70M4.72M
Total Debt499.28K1.03M1.75M2.28M1.99M2.74M1.82M
Net Debt-923.69K-6.27M363.00K-1.86M-2.18M-3.96M-2.90M

Cash Flow

Currency: PLN2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-1.69M-2.52M-5.53M-3.79M-7.95M-6.72M-11.38M
Investing Cash Flow-508.99K-79.00K-213.00K-4.33M-3.80M-380.00K-92.00K
Financing Cash Flow3.29M8.47M-196.00K10.89M11.80M9.62M9.50M
Capital Expenditure490.69K127.00K213.00K4.33M3.53M59.00K92.00K
Free Cash Flow-2.19M-2.64M-5.74M-8.12M-11.48M-6.78M-11.48M
FCF to OCF128.96%105.05%103.85%214.42%144.35%100.88%100.81%

Earnings

Report DateMar 31, 2021Jun 30, 2021Sep 30, 2021Mar 31, 2022Jun 30, 2022Sep 30, 2022Dec 31, 2022Mar 31, 2023Sep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026
EPS Estimate-------------------
EPS Actual-0.22-0.12-0.12-0.09-0.35-0.19-0.70-0.20-0.23-0.18-0.22-0.25-0.25-0.14-0.22-0.23-0.17-0.09-0.15
Surprise-------------------
Timing-------------------

Key Statistics & Ratios

Market Cap51.45M
Enterprise Value59.58M
Trailing P/E0.00
Forward P/E0.00
Price / Sales1715.00
Price / Book8.60
EPS-0.62
Book Value0.625
Revenue (TTM)30.00K
Gross Profit (TTM)-8.10M
EBITDA-6.06M
Profit Margin0.00%
Operating Margin-13387.50%
Return on Equity-83.04%
Return on Assets-29.09%
Shares Outstanding17.06M
Shares Float9.77M
Beta0.31
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%